{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:07Z","timestamp":1758971407295,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.annder.2008.10.036","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T04:43:13Z","timestamp":1235623393000},"page":"355-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Carcinomes basocellulaires multiples apr\u00e8s traitement d\u2019un psoriasis par \u00e9tanercept"],"prefix":"10.1016","volume":"136","author":[{"given":"C.","family":"Maire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Delesalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lequint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Delaporte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2008.10.036_bib1","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.10.036_bib2","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2008.10.036_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1517\/14740338.7.5.539","article-title":"Risk of skin cancer in the drug treatment of rheumatoid arthritis","volume":"7","author":"Chakravarty","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.annder.2008.10.036_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M","article-title":"Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome","volume":"69","author":"Kimonis","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.annder.2008.10.036_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2004.06030.x","article-title":"Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor","volume":"151","author":"Walther","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.036_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00241633","article-title":"Genetic basis of the effects of ultraviolet light B on cutaneous immunity: evidence that polymorphism at the Tnfa and Lps loci governs susceptibility","volume":"32","author":"Yoshikawa","year":"1990","journal-title":"Immunogenetics"},{"key":"10.1016\/j.annder.2008.10.036_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jsbmb.2004.03.071","article-title":"Role for tumor necrosis factor-alpha in UVB-induced conversion of 7-dehydrocholesterol to 1-alpha,25-dihydroxyvitamin D3 in cultured keratinocytes","volume":"89-90","author":"Lehmann","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.annder.2008.10.036_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.0906-6705.2003.00085.x","article-title":"Basal cell carcinoma is associated with high TNF-alpha release but nor with TNF-alpha polymorphism at position-308","volume":"12","author":"Skov","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2008.10.036_bib9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/10552","article-title":"Mice deficient in tumor necrosis factor-\u03b1 are resistant to skin carcinogenesis","volume":"5","author":"Moore","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.annder.2008.10.036_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1359-6101(01)00020-X","article-title":"Tumor necrosis factor or tumor promoting factor?","volume":"13","author":"Balkwill","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.annder.2008.10.036_bib11","unstructured":"NICE Guidelines. Guidance for the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Technology Appraisal 2002; 36:17."},{"key":"10.1016\/j.annder.2008.10.036_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2008.10.036_bib13","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2008.10.036_bib14","first-page":"2130","article-title":"Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors","volume":"32","author":"Chakravarty","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2008.10.036_bib15","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/rheumatology\/kem214","article-title":"Skin cancer in psoriatic arthritis treated with anti-TNF therapy","volume":"46","author":"Sheppard","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.annder.2008.10.036_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2133.2000.03353.x","article-title":"Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas","volume":"142","author":"Hajeer","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.036_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00008571-200104000-00008","article-title":"Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype","volume":"11","author":"Ramachandran","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.annder.2008.10.036_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/rheumatology\/keh514","article-title":"Guideline for anti-TNF\u03b1 therapy in psoriatic arthritis","volume":"44","author":"Kyle","year":"2005","journal-title":"Rheumatology"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:55:26Z","timestamp":1758970526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963809000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0151963809000350"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2008.10.036","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carcinomes basocellulaires multiples apr\u00e8s traitement d\u2019un psoriasis par \u00e9tanercept","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2008.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}